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Abstract
Background
The highest burden of disease from hepatitis C virus (HCV) is found in Southeast Asia, but
our understanding of the epidemiology of infection in many heavily burdened countries is
still limited. In particular, there is relatively little data on acute HCV infection, the outcome of
which can be influenced by both viral and host genetics which differ within the region. We
studied HCV genotype and IL28B gene polymorphism in a cohort of acute HCV-infected
patients in Southern Vietnam alongside two other cohorts of chronic HCV-infected patients
to better understand the epidemiology of HCV infection locally and inform the development
of programs for therapy with the increasing availability of directly acting antiviral therapy
(DAAs).
Methods
We analysed plasma samples from patients with acute and chronic HCV infection, including
chronic HCV mono-infection and chronic Human Immunodeficiency Virus (HIV)-HCV coin-
fection, who enrolled in four epidemiological or clinical research studies. HCV infection was
confirmed with RNA testing. The 5’ UTR, core and NSB5 regions of HCV RNA positive sam-
ples were sequenced, and the genotype and subtype of the viral strains were determined.
Host DNA from all HCV positive patients and age- and sex-matched non-HCV-infected con-
trol individuals were analysed for IL28B single nucleotide polymorphism (SNP) (rs12979860
and rs8099917). Geolocation of the patients were mapped using QGIS.
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355 HCV antibody positive patients were analysed; 54.6% (194/355) and 46.4% (161/355)
were acute and chronic infections, respectively. 50.4% (81/161) and 49.6.4% (80/161) of
chronic infections had HCV mono-infection and HIV-HCV coinfection, respectively. 88.7%
(315/355) and 10.1% (36/355) of the patients were from southern and central regions of
Vietnam, respectively. 92.4% (328/355) of patients were HCV RNA positive, including
86.1% (167/194) acute and 100% (161/161) chronic infections. Genotype could be deter-
mined in 98.4% (322/328) patients. Genotypes 1 (56.5%; 182/322) and 6 (33.9%; 109/322)
predominated. Genotype 1 including genotype 1a was significantly higher in HIV-HCV coin-
fected patients compared to acute HCV patients [43.8% (35/80) versus 20.5% (33/167)],
(p = <0.001), while genotype 6 was significantly higher in chronic HCV mono-infected
patients [(44.4% (36/81) versus 20.0% (16/80)] (p = < 0.004) compared to HIV-HCV coin-
fected patients. The prevalence of IL28B SNP (rs12979860) homozygous CC was 86.46%
(83/96) in control individuals and was significantly higher in acutely-infected compared to
chronically-infected patients [93.2 (82/88) versus 76.1% (35/46)] (p = < 0.005).
Conclusion
HCV genotype 6 is highly prevalent in Vietnam and the high prevalence in treatment naïve
chronic HCV patients may results from poor spontaneous clearance of acute HCV infection
with genotype 6.
Introduction
Hepatitis C virus (HCV) infection is a major public health threat, and the Global Health Sector
Strategy (GHSS) on viral hepatitis 2016–2021 calls for the elimination of viral hepatitis, reduc-
ing new infections by 90% and mortality by 65% by 2030 [1]. The World Health Organization
(WHO) estimates that approximately 71 million people are suffering from chronic HCV infec-
tion globally, and annually 700,000 people die from HCV-related complications, including
liver cirrhosis and hepatocellular carcinoma (HCC) [1]. African continent have highest HCV
disease burden followed by Asia (2.8% and 2.7% seroprevalence respectively) [2]. One fifth of
the global HCV burden (14/71 million) is in Western Pacific Region which includes Vietnam
[1]. HCV transmission results from direct exposure to contaminated blood and is associated
with injectable drug use (IDU), iatrogenic exposure (blood transfusion, surgical and dental
procedures, dialysis, acupuncture, needle stick injury, and use of unsterilized needles), body
piercing and less frequently, through vertical transmission and high risk sexual behavior [3, 4].
Acute HCV infection is infrequently diagnosed as the majority of acutely infected individuals
are asymptomatic [5]. After acute infection, approximately 75–85% of patients do not clear the
virus by six months and develop chronic HCV infection [5]. Progression to chronic HCV
infection depends on several factors, including the age at the time of infection, gender, ethnic-
ity, host genetic factors, immune status, development of jaundice during acute infection and
viral genotype and subtype [6]. It is estimated that chronic HCV infection accounts for 20% of
HCC globally [7]. HCV related HCC is more prevalent in countries where HCC prevalence is
low (Western Europe and North America) or intermediate (Japan, Italy and Spain) [7–10].
Epidemiology of hepatitis C genotypes in Vietnam
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HCV is classified into seven genotypes 1–7; each genotype is further divided into a variable
number of more closely related subtypes (currently more than 100 subtypes) [11]. The natural
course of infection, pathogenesis, treatment regimens, treatment duration and outcomes
largely depend on genotype and subtype of the infecting HCV strain [12, 13]. For examples,
the rate of evolution to chronicity is higher in genotype 1b compared to other genotypes (92%
versus 33–50%) [14]. A recent case control study has documented the association between
genotype 1b and HCC and the multivariate adjusted odds ratio of developing HCC for HCV
genotype 1b compared to non-1b was 1.65 (95% confidence interval (CI); 1.16–2.33) [15]. Dif-
ferent transmission routes for HCV infection has shown to be associated with the genotype of
the virus. Subtype 1b transmits effectively via blood transfusion, while subtypes 1a and 3a
transmit predominantly through IDU [16].
Besides genotype, host factors such as single-nucleotide polymorphisms (SNP) of IL28B
(rs12979860 and rs8099917) in the upstream of IL28B gene on chromosome 19 have been
shown to be associated with spontaneous clearance of acute HCV infection, jaundice during
acute infection and sustained viral response (SVR) on pegINF/ribavirin(RBV) treatment [17,
18]. Patients who are homozygous carriers of cytosine (CC) at position rs12979860, have a
much higher likelihood of spontaneous clearance compared to homozygous thiamine TT or
heterozygous CT [(64%; 43/67) versus (6%; 2/33) and (24%; 22/90)] respectively (p<0.001).
Jaundice during acute infection is more common among patients with CC genotype than non-
CC patients (CT or TT) (32.7% versus 16.1%) [18].
HCV genotypes have distinct geographic distribution. Genotype 6 is more prevalent in
Southeast Asian countries [19], including Southern China, Myanmar, Laos, Vietnam and
Cambodia [2, 20–22]. Genotype 6 is the most diverse with 31 subtypes currently recognized
and has shown to have emerged and evolved in Southeast Asia [23]. Genotype 6 has also iden-
tified in industrialized countries such as Canada and Australia from a Southeast Asian linage
due to population immigration [24].
Vietnam is amongst the 20 countries with the highest burden of HCV in the world with an
estimate of 1.5 million chronic HCV infected people (estimated HCV RNA prevalence 1.1%)
(https://www.who.int/westernpacific/health-topics/hepatitis/regional-hepatitis-data). The
prevalence of positive HCV antibody among the general population is between 1% and 4.7%
[25–28], but is substantially higher among HIV-infected individuals (22.9–89.0%), IDUs
(74.0% - 87.0%), and multi transfusion and dialysis patients (6.0–26.6%) [23, 29–32]. Vietnam
has recently revised its national guidelines for the treatment of HCV infection, and access to
affordable generic DAAs for HCV infection is rapidly expanding. However, knowledge of the
molecular epidemiology of HCV infection and the host genetic diversity among HCV infected
populations in Vietnam are lacking. In order to inform the development of HCV treatment
programs in country, we analyzed HCV RNA positive samples from four epidemiological and
clinical studies in Vietnam. Our specific aims were to i) determine the differential prevalence
and geographical distribution of HCV genotypes and subtypes in acutely HCV infected and
chronically HCV-infected patient populations ii) determine the differential prevalence of
IL28B SNP (rs12979860 and rs8099917) among acutely HCV-infected and chronically HCV-
infected patient populations in Vietnam.
Materials and methods
Ethics statement
All studies were approved by ethical review committee of the Hospital for Tropical Diseases
(HTD) in Ho Chi Minh City (HCMC) and Oxford Tropical Research Ethics Committee
Epidemiology of hepatitis C genotypes in Vietnam
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Table 1. Study title, ethical approval, inclusion/exclusion criteria, study sites, study duration, sample size, number (percentage) of HCV positive patients and types
of HCV infection.
SL
No
Study title OxTREC
approval
HTD
approval
Inclusion & exclusion criteria Study site Study
period
Sample
size
HCV
positive n
(%)
HCV infection
status
1 Epidemiology and etiology of
viral hepatitis and molecular
characterization of Hepatitis B
and C virus isolated from
patients attending at Hospital
for Tropical Diseases (HTD) in
Ho Chi Minh City (HCMC),
Vietnam.
OxTREC;
152–12
SC/ND/
12/14
Inclusion criteria:
• symptom consistent with
acute viral hepatitis (e.g., fever,
headache, malaise, anorexia,
nausea, vomiting, diarrhea,
AND abdominal pain
• aged�1 year
• written informed consent,
• total bilirubin�50 mmol/l or
�3 mg/dl and/or
• ALT�200 international unit
Exclusion criteria
• previously diagnosed as
having hepatitis of any etiology
• previous enrolment in this
study,
• known to have liver cirrhosis,
hepatocellular carcinoma, or
other terminal illness, and
• alcoholic hepatitis, or drug or
toxin induced hepatitis.
1.Hospital for
Tropical
diseases; Ho
Chi Minh
City,
Jan 2015 to
May 2016
737 96 (13.0) Acute
infection
2 The etiology of diarrhea,
hepatitis, respiratory infections
and central nervous system
infections in provincial
hospitals in Vietnam
OxTREC;
15–12
SC/ND/
13/28
Inclusion criteria:
• symptom consistent with
acute viral hepatitis (e.g., fever,
headache, malaise, anorexia,
nausea, vomiting, diarrhea, and
abdominal pain
• aged�1 year
• written informed consent,
• total bilirubin of �50 mmol/l
or�3 mg/dl and
• ALT�200 international unit
(IU)/liter (L).
Exclusion criteria:
• previously diagnosed as
having hepatitis of any etiology
• previous enrolment in this
study,
• known to have liver cirrhosis,
hepatocellular carcinoma, or
other terminal illness, and
• alcoholic hepatitis, or drug or
toxin induced hepatitis.
1. Hospital for
Tropical
diseases; Ho
Chi Minh
City,
2. National
Hospital for
Tropical
Diseases,
Hanoi
3. Hue
provincial
hospital, Hue
4. Khanh Hoa
provincial
hospital,
Khanh Hoa
5. Dak Lak
provincial
hospital, Dak
Lak
6. Dong Nai
provincial
hospital, Dong
Nai
7. Dong Thap
provincial
hospital, Dong
Thap
Jan 2013 to
Oct 2016
1089 98 (8.9) Acute
infection
(Continued)
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Table 1. (Continued)
SL
No
Study title OxTREC
approval
HTD
approval
Inclusion & exclusion criteria Study site Study
period
Sample
size
HCV
positive n
(%)
HCV infection
status
3 Molecular characterization of
Hepatitis B and C virus isolated
from patients attending at
Hospital for Tropical Diseases
(HTD) in Ho Chi Minh City
(HCMC), Vietnam.
OxTREC;
5–12
SC/ND/
12/4
Inclusion criteria:
• No symptom consistent with
acute viral hepatitis
• previously diagnosed as
hepatitis C positive
• HCV RNA positive for at
least 1 year
• aged�1 year
• written informed consent
Exclusion criteria
• previous enrolment in this
study,
• known to have liver cirrhosis,
hepatocellular carcinoma, or
other terminal illness, and
• alcoholic hepatitis, or drug or
toxin induced hepatitis.
1.Hospital for
Tropical
diseases; Ho
Chi Minh
City,
Jan 2012 to
December
2014
81 81 (100) Chronic
infection
4 Hepatic Safety of Raltegravir-
based and Efavirenz-based
Antiretroviral Regimens in
Antiretroviral-Naïve HIV-
infected Subjects Co-Infected
with Hepatitis C
OxTREC-
36–10
CS/ND/
10/15
Inclusion criteria:
• HIV infected patients, age
�18 years, meet Vietnam
guideline to begin ART (CD4
count < 350 cells/mm3 and/or
WHO stage III or IV disease)
• Hepatitis C infection as
documented by positive HCV
antibodies and a detectable
serum HCV RNA level
• AST and ALT� 2 x ULN
(� 80 U/L)
• Estimated creatinine
clearance� 60 mL/min
(Calculation by Cockcroft and
Gault: (140 –age in years) ×
(body weight in kg)� (serum
creatinine in mg/dL × 72). For
women, multiply by 0.85
Exclusion criteria:
• Any prior ART
• Positive Hepatitis B surface
antigen
• Clinical evidence of de-
compensated cirrhosis (ascites,
encephalopathy, esophageal
bleeding)
• Requirement for acute
therapy for other AIDS-
defining illness within 14 days
prior to study entry
• Currently on rifampicin
therapy
• In the first trimester of
pregnancy, intent to become
pregnant, or breast feeding
during the study period
1.Hospital for
Tropical
diseases; Ho
Chi Minh
City,
June 2013 to
June 2017
80 80 (100) Chronic
infection
(HIV-HCV
co-infection)
HTD; Hospital for Tropical diseases
https://doi.org/10.1371/journal.pone.0212734.t001
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(Table 1). Written informed consent was mandatory for entry into all the studies, written
informed consent was requested from a parent or guardian from those aged<16 years.
Case definition
HCV infection in this study was defined as per the Council of State and Territorial Epidemiologists
(CSTE) case definition, (https://wwwn.cdc.gov/nndss/conditions/hepatitis-c-probable acute/case-
definition/2016/, https://wwwn.cdc.gov/nndss/conditions/hepatitis-c-chroniCCase-definition/
2016/). Briefly, the case definition for acute HCV infection is defined as having a discrete onset of
symptoms consistent with acute hepatitis (e.g., nausea, anorexia, fever, malaise, or abdominal
pain) AND either jaundice or elevated serum aminotransferase levels>200 IU/L during the period
of acute illness AND a positive HCV RNA amplification test. A case definition for chronic HCV
infection is defined as having no clinical or laboratory evidence indicative of acute hepatitis
(above) AND a positive HCV antibody test AND a positive HCV RNA test.
Study population
Plasma samples from 355 HCV positive (either HCV antibody or antigen or HCV nucleic acid
test (NAT) positive) patients recruited in four epidemiological and clinical research studies
conducted in Vietnam from 2012 to 2016 were included in this study. Information about the
study title, ethical approval, inclusion and exclusion criteria, enrollment sites, study duration,
sample size, number of HCV positive samples and types of HCV patients are presented in
Table 1. Among the HCV positive patients, 194 were classified as acute infection, and 161 as
chronic infection including 81 chronic HCV mono-infection and 80 HIV-HCV coinfection.
These studies were conducted in seven provincial hospitals across Vietnam. In addition,
plasma samples from ninety-six age (± 5 years) and sex matched HCV-negative patients
attended to the Hospital for Tropical Diseases (HTD) between 2013 and 2016 were used as
control group for the IL28B SNP analysis. Sociodemographic data, geolocation information
(province, district, and city), clinical data, along with laboratory data on hematology, chemis-
try (aspartate aminotransferase (AST) alanine aminotransferase (ALT), bilirubin, Gamma-glu-
tamyl transpeptidase (GTT), alpha fetoprotein (AFP)), serological tests for hepatitis viruses
were extracted from respective study database. Anti HCV antibody was detected by AiDTM
anti-HCV ELISAPlus (Beijing Wantai Biological Pharmacy Enterprise Co., Ltd, China) test as
per manufacturer specification (sensitivity 100%, specificity 99.96).
HCV RNA detection and genotyping
Viral RNA was extracted from 140 μl of plasma using MagNa pure 96 DNA and viral NA
small volume kit (Roche Diagnostics, Basel). Viral RNA was reverse transcribed using super-
script III reverse transcriptase protocol as described earlier [22]. The resulting cDNA was used
for amplification of 236 bp 5’UTR, 377 bp NSB5 and 464 bp core region using primers through
nested PCR as described earlier [22]. Amplicons were run on 1.5% agarose gel (Merck, Ger-
many) and purified using the Agincourt AMPure XP (Beckman Coulter, Inc) according to the
manufacturer’s protocol. Purified amplicons were sequenced both forward and reverse direc-
tion using Big Dye Terminator Cycle Sequencing Ready Reaction Kit and Applied Biosystems
3130xl Genetic Analyzer (Applied Biosystems).
The nucleotide sequences were aligned and the consensus sequence was generated. This
includes 236 bp 5’UTR (position 78 to 314), 464 bp core sequence (position 288 to 752) and
377 bp NS5B (position 8259 to 8636) of GenBank sequence AY051292. Forty seven well char-
acterized HCV whole genome sequences representing all genotypes and subtypes were down-
loaded from GenBank and used as reference sequences [11]. The reference sequences and the
Epidemiology of hepatitis C genotypes in Vietnam
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sequences from the current study were subjected to phylogenetic analysis using Genious 8.0.5
software package (http://www.geneious.com). NSB5 sequences (if NS5B sequence is not avail-
able, core or 5’UTR sequences respectively) from the present study and the corresponding
region of reference sequences were aligned with MUSCLE alignment program available within
the Genious package. The sequence alignments were then subjected to Jmodel test to identify
the best model for phylogenetic analysis [33]. The suggested nucleotide substitution model
(GTR+G+I) was subsequently used in phylogenetic analysis using Neighbor-Joining method
(available in Genious package). To confirm the reliability of phylogenetic tree analysis, boot-
strap resampling and reconstruction were carried out 1000 times. All sequences from this
study was submitted to GenBank (accession numbers for 5’UTR MH191406—MH191721;
core region MH191722—MH192024 and, NS5B region MH192025—MH192337).
IL28B polymorphism determination
96 controls and randomly selected 88 acute and 83 chronic (including 46 chronic mono-infec-
tions and 37 HIV-HCV coinfection) HCV patients’ samples were used for IL28B SNP assess-
ment. DNA was extracted from stored cell pellets using the DNeasy blood and tissue kit
(Qiagen, Germany) according to the manufacturer’s protocol. SNPs (rs8099917 and rs1297
9860) in IL28B gene were determined with the TaqMan SNP Genotyping assay (Applied Bio-
systems, Foster City, CA,). SNP at rs12979860 (CC, CT and TT genotypes), and rs8099917
(TT, GT and GG genotypes) were determined according to manufacturer’s protocol. SNP at
rs12979860 (CC, CT and TT genotypes) and rs8099917 (TT, GT and GG genotypes) was com-
pared between acute and chronic HCV patients and control group.
Data analysis
All data extracted from the respective study database were analysed using Statistical Package
for Social Science (SPSS) software (IBM SPSS Statistics 23, NY USA). The geo-location data of
the patients were analyzed by GIS package version 2.18. Cases from northern regions of Viet-
nam were excluded from the geolocation analyses due to low patient numbers. Categorical var-
iables were compared with Chi-square test and continuous variables by Student’s t-test. One
way ANOVA was used to compare proportions between multiple groups. A p value<0.05 was
regarded as statistically significant.
Results
Baseline data
A total of 355 HCV positive samples were available for analysis in this study. Among these,
54.6% (194/355), 22.8% (81/355) and 22.4% (80/355) were classified as acute HCV infection,
chronic HCV mono-infection, and HIV-HCV coinfection, respectively. Among 194 acutely-
infected HCV patients, 86.1% (167/194) was HCV RNA positive and were included for further
analysis. All 161 chronically HCV-infected patients were HCV RNA positive. Overall, 92.4%
(328/355) were HCV RNA positive only; 84.2% (299/355) of the patients were both HCV anti-
body and HCV RNA positive; and 91.8% (326/355) were HCV antibody positive only. 8.8%
(29/328) of HCV RNA positive samples were HCV antibody negative, and 8.3% (27/326) of
HCV antibody positive samples were HCV RNA negative.
The sociodemographic information of the patients are presented in Table 2. 59.3% (195/
328) were male including the majority (87.5%; 70/80) of the patients in HIV-HCV coinfection
group. The mean age of acute, chronic HCV mono-infected and HIV-HCV co-infected
patients were 42 years, 48 years, and 35 years, respectively. Among all patients, 6.7% (24/355)
Epidemiology of hepatitis C genotypes in Vietnam
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were Hepatitis B surface antigen (HBs Ag) positive, including 10.8% (21/194), and 3.7% (3/81)
in acute and chronic HCV mono-infection respectively.
Geolocation of patients
88.7% (315/355) of the patients were from the southern regions, including 60.5% (215/355)
from the Southeast sub region, and 28.1% (100/355) from the Mekong Delta sub region. 10.1%
(36/355) from the central regions including 3.9% (14/355) from the Central Highlands sub
region, 1.4% (5/355) from the North Central Coast sub region, and 4.8% (17/355) from the
South Central Coast sub region (S1 Table).
HCV genotyping
HCV RNA positive samples (n = 328) were included for HCV genotype analysis. Any HCV
RNA region (5’UTR, core, and NS5B) could be amplified and sequenced in 98.2% (322/328) of
Table 2. Socio demographic characteristics and prevalence of genotypes and subtypes of Hepatitis C PCR positive patients analyzed in the study.
All patient Acute infection Chronic infection HIV-HCV coinfection P3 pᶞ
100% (328) 50.9% (167) 24.7% (81) 24.4% (80)
% (n) % (n) % (n) % (n)
Age 0–20 1.2 (4) 2.4 (4) 0.0 (0) 0.0 (0)
21–30 16.2 (53) 23.4 (39) 6.2 (5) 11.3 (9)
31–40 36.6 (120) 26.9 (45) 13.6 (11) 80.0 (64)
41–88 46.0 (151) 47.3 (79) 80.2 (65) 8.8 (7) 0.000���
Gender Male 59.3 (195) 48.8 (81) 53.1 (43) 87.5 (70)
Female 40.7 (133) 51.2 (85) 46.9 (38) 12.5 (10) 0.000���
Genotype b Subtype b
1 56.5 (182) 50.9 (82) 46.9 (38) 77.5 (62) 0.000���
1a 27.6 (89) 20.5 (33) 25.9 (21) 43.8 (35) 0.001��
1b 28.9 (93) 30.4 (49) 21.0 (17) 33.7 (27) 0.169
2 7.5 (24) 9.9 (16) 8.6 (7) 1.3 (1) 0.048�
2a 4.0 (13) 5.0 (8) 4.9 (4) 1.3 (1) 0.346
2b 0.6 (2) 1.2 (2) 0.0 (0) 0.0 (0) 0.368
2m 2.8 (9) 3.7 (6) 3.7 (3) 0.0 (0) 0.218
3 2.2 (7) 3.7 (6) 0.0 (0) 1.3 (1) 0.14
3a 0.9 (3) 1.9 (3) 0.0 (0) 0.0 (0) 0.222
3b 1.2 (4) 1.9 (3) 0.0 (0) 1.3 (1) 0.469
6 33.9 (109) 35.4 (57) 44.4 (36) 20.0 (16) 0.004��
6a 18.3 (59) 18.6 (30) 19.8 (16) 16.3 (13) 0.84
6e 12.1 (39) 12.4 (20) 19.8 (16) 3.8 (3) 0.008��
6h 0.3 (1) 0.6 (1) 0.0 (0) 0.0 (0) 0.608
6k 0.3 (1) 0.0 (0) 1.2 (1) 0.0 (0) 0.226
6l 2.2 (7) 2.5 (4) 3.7 (3) 0.0 (0) 0.256
6p 0.6 (2) 1.2 (2) 0.0 (0) 0.0 (0) 0.368
� p = 0.01–0.05
�� p<0.001–0.01
��� p<0.001.
b Data available for 322 patients (161 acute infection, 81 chronic infection and 80 HIV-HCV coinfection)
ᶞ p value between chronic HCV mono-infection and HIV-HCV coinfection determined by Chi square for nominal and Man Whitney test for continuous variables.
ᶾ p value between acute HCV, chronic HCV mono-infection and HIV-HCV coinfection as determined by one way ANOVA test
https://doi.org/10.1371/journal.pone.0212734.t002
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samples and all three regions could be amplified and sequenced in 87.8% (288/328) of the sam-
ples. The phylogenetic analysis using the NS5B and core region are presented in Fig 1. All Viet-
namese isolates belong to four genotypes (1, 2, 3, and 6) and 13 subtypes (1a, 1b, 2a, 2b, 2m,
3a, 3b, 6a, 6e, 6h, 6k, 6l, and 6p) (Table 2). The overall prevalence of genotype 1, 2, 3 and 6 was
56.5% (182/322), 7.5% (24/322), 2.2% (7/322), 33.9% (109/322), respectively (Table 2). All
genotype 1 isolates belong to subtype 1a or 1b. Among genotype 6 isolates, the majority were
subtype 6a (54.1%; 59/109) and 6e (35.8%; 39/109). The prevalence of genotype 1a in
HIV-HCV coinfection group was significantly higher than in acute or chronic HCV mono-
infection groups, 43.8% (35/80) versus 20.5% (33/176) and 25.9% (21/81), respectively,
Fig 1. A midpoint rooted tree showing the relationship between the Vietnamese HCV (n = 322) sequences with 43 reference sequences downloaded from the
GenBank database (all genotypes and selected subtypes). Tree was constructed using Neighbor-Joining method available in Genious software using GTR+G+I
nucleotide substitution model with 1000 bootstrapping replicates. Bootstrap values greater than 70% is shown on the branch nodes. Acute, chronic mono-infection and
HIV-HCV coinfection is presented by suffix A (in black text), suffix C (in blue text) and suffix H (in purple text) followed by the patient ID and sequence region
respectively. The reference genomes are presented as subtype followed by Gene Bank accession number and country of origin. The reference genomes are highlighted
with a filled dark circle. The scale bar indicates the number of nucleotide substitution. Red, purple, green, and brown color is used for genotype 1, 2, 3, and 6. (a)
Analysis was based on a 377 bp HCV NS5B gene (position 8259 to 8636 relative to GenBank sequence AY051292). Sequences with discordant genotype between NS5B
and 5 UTR, and NS5B and core is marked with � and �� respectively. (b) Analysis was based on a 464 bp core sequence (position 288 to 752) relative to GenBank
sequence AY051292). Sequences which have discordant genotype between core and 5’UTR with NS5B is marked with ���.
https://doi.org/10.1371/journal.pone.0212734.g001
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(p<0.001, one-way ANOVA test). Genotype 6 was significantly higher in chronic HCV mono-
infection patients compared to acute or HIV-HCV co-infection group (44.4%; 36/81 versus
33.4%;57/161 and 20%; 16/80 respectively) (p = 0.004, one-way ANOVA test).
The distribution of HCV genotypes among different geographic regions were analysed and
presented in Fig 2. HCV genotype 1 accounted for more than half of isolates in all sub regions.
Fig 2. Geographical distribution of HCV genotypes in different sub regions of Vietnam. Sub regions are presented
by different colors. Number of isolates and proportion of different genotypes in each sub region are presented in blue
(genotype 1), green (genotype 2), red (genotype 3) and purple (genotype 6) colors.
https://doi.org/10.1371/journal.pone.0212734.g002
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More than one third of the viral strains from the southern regions were genotype 6, including
66.3% (67/101) in the South East and 33.7% (34/101) in the Mekong Delta sub region. 25% of
isolates from the Central Highlands sub region was genotype 3. 10% (9/91) and 7.0% (15/204)
of the viral strains in Mekong Delta and South east sub region was genotype 2.
We evaluated the concordance of genotype determination by each individual genetic region
(NS5B, core and 5’UTR) in 288 strains with all three region sequenced. Discordant in geno-
types was identified in 43 (14.9%; 43/288) viral strains. The discordance was observed in 36
strains (12.5%; 36/288) when the 5’UTR region based genotype was compared with the NS5B
and core based genotypes (genotype 6e is being identified as genotype 1a or 1b). The discor-
dance was observed in 6 (2.0%; 6/288) and one (0.3%; 1/288) strains when the core based geno-
type was compared with the NS5B and 5’UTR based genotype, and the NS5B based genotypes
was compared with the core and 5’UTR based genotype respectively. Among the discordant
genotype strains, 93.0% (40/43) was genotype 6 including 75.0% (30/40) subtype 6e (Fig 1A
and 1B sequences with � asterisk mark). In 7 isolates (2.4%; 7/288), the genotypes defined by
the core gene were different from that of the NS5B gene indicating a possible mixed infection
(Fig 1A and 1B sequences with �� and ��� asterisk mark). The homology of 5’UTR, core and
NS5B sequence of these viral strains with the reference strains are presented in S2 Table. All
possible mixed infection sequences belonged to genotype 1 or 6. Six of these seven viral strains
were identified from chronically HCV-infected patients including five from HIV-HCV coin-
fected and one from HCV mono-infected patients. We further examined the diversity of the
sequence within acute, chronic mon-infected and HIV-HCV co-infected patients. The diver-
sity was higher among viral strains from acutely infected compared to chronically infected
patients (NS5B; 92.3% similarity in acute strains versus 95.7% in chronic infection strains) (Fig
1A and 1B).
We examined the association between HCV genotypes and liver enzyme (AST, ALT, biliru-
bin, GTT, AFP) and HCV RNA measurement in acute, chronic HCV mono-infection and
HIV-HCV coinfection. Liver enzyme and HCV RNA levels were significantly higher in
acutely-infected patients compared to chronically-infected patients. No significant differences
in the liver enzymes and HCV RNA levels were observed between the different genotypes
within these three patient groups. All statistical comparisons are presented in the S3 Table.
Prevalence of IL28B SNP among different groups
The IL28B SNP (rs12979860 and rs8099917) was analysed in 267 patients including 88, 46, 37
and 96 acute, chronic HCV mono-infection, HIV-HCV coinfection, and control patients
respectively (Fig 3). For the rs12979860, 228 of 267 patients (85.39%, [95% CI, 81.03% to
89.55%]) were homozygous for CC, 1 (0.37% [95% CI, -0.35% to 1.09%]) were homozygous
for TT and, 38 (14.23% [95% CI, 10.11% to 18.35%]) was heterozygous. There was no signifi-
cant difference in CC prevalence between HCV-negative control group and acute HCV group
(86.46%; 83/96 versus 93.18%; 82/88), p = 0.134, Chi Square test. However, the prevalence of
CC allele was significantly higher in acute HCV patients compared to chronic HCV patients
(93.18%; 82/88 versus 76.09%; 35/46), p = 0.002, Chi Square test (Fig 3A).
For the rs8099917, 235 of 267 patients (88.01% [95% CI, ±3.83; 84.18% to 91.84%]) were
homozygous for TT, 5 (1.87% [95% CI, ± 1.62; 0.27% to 3.47%]) were homozygous for G/G
and, 27 (10.11% [95% CI, ±3.56; 6.55% to 13.67%]) were heterozygous (G/T). There was signif-
icant difference in TT prevalence between control group and acute HCV patients (87.50%; 84/
96 versus 94.32%; 83/88) p = 0.007, Chi Square test, and between acute and chronic HCV
patients (94.32%; 83/88 versus 80.43%; 37/46), p = 0.001, Chi Square test (Fig 3B).
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Discussion
HCV pathogenesis depends on host and viral factors including host genetics, the genotype and
subtypes of the infecting viral strain [34]. The prevalence of HCV genotype among IDUs, dial-
ysis and multi-transfusion and HIV patients have been reported earlier; however, data on
HCV genotype among the general population and especially in acute HCV infection are lack-
ing in Vietnam [22, 35–42]. By collating data from four hospital based studies in Vietnam to
identify the prevalence HCV genotype and to examine the geographic distribution of geno-
types, we identified a high genetic diversity in HCV, illustrating a polyphyletic nature of the
HCV epidemic in Vietnam. Genotype 1 was predominant, with nearly half of the acute and
chronic HCV mono-infection and three fourth of the HIV-HCV coinfection groups. This is
consistent with earlier studies in Vietnam, one of which documented a high (60.0%) preva-
lence of genotype 1 in IDUs [30]. HIV-HCV coinfected patients had the highest prevalence of
subtype 1a (43.8% compared to 20.5% in acute and 25.9% in HCV monoinfected patients. Sub-
type 1a has been shown to be common in male with high risk behaviors in Europe and Amer-
ica, e.g. IDUs, men who have sex with men (MSM), and is more commonly transmitted
through IDU [36, 43–45]. It is likely that HCV subtype 1a is being efficiently circulated
through IDU as a shared risk behavior for both HIV and HCV transmission. In HIV-infected
Fig 3. The prevalence of IL28B SNP (rs12979860 and rs8099917) in 171 patients. 88 acute, 46 chronic HCV mono-infection and 37 HIV-HCV coinfection
and 96 age (±5 years) and sex matched non hepatitis control patients. The percent prevalence of SNPs is presented in Y axis and the patient groups and controls
in X axis. P value was calculated using chi square and fisher’s exact test as appropriate. (A) The prevalence CC, CT and TT for rs8099917. The proportion of
CC, CT and TT alleles are presented in green, orange and blue color bars respectively. P value was calculated between control and all groups (acute HCV,
chronic HCV mono-infection and HIV-HCV coinfection) individually and acute HCV and chronic HCV mono-infection group. (B) The prevalence TT, T/G
and G/G for rs12979860. The proportion of TT, GT and GG alleles are presented in green, orange and blue color bars respectively. P value was calculated
between control and all groups (acute HCV, chronic HCV mono-infection and HIV-HCV coinfection) individually and acute HCV and chronic HCV mono-
infection group.
https://doi.org/10.1371/journal.pone.0212734.g003
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individuals, spontaneous clearance of acute HCV infection is rare; therefore it is likely that
most of the HIV-HCV coinfection patients in our study were infected with HCV genotype 1,
which was not subsequently cleared [44]. Subtype 1b was predominant in acutely infected
patients in our study (28.9%; 93/328). Subtype 1b is also the predominant subtype in Vietnam’s
neighboring countries, accounting for 66% of HCV infection in China, 64.4% in Japan, and
66% in South Korea [46–48], and is also a major subtype in Europe [46]. HCV subtype 1b has
been shown in the 1990s to be associated with blood transfusion and unsafe medical injections
[49]. It might be possible that genotype 1b has introduced to Vietnam from neighboring coun-
tries and subsequently spread in the country via transfusion or unsafe medical practices or
population movement.
Genotype 6 was the second most common genotype across all study groups. Genotype 6 is
the most genetically diverse among HCV genotypes and is known to contain the highest preva-
lence of preexisting variants conferring resistance to DAAs [35, 50]. It has been hypothesized
that genotype 6 has evolved from the Vietnam Mekong Delta region [22, 23, 41]. One third of
the viral strains in our study was genotype 6 including six subtypes demonstrating its diversity
and abundance in southern Vietnam. The most predominant subtypes were 6a (18.3%; (59/
322) followed by 6e (12.1%; 39/322). The prevalence of genotype 6 as well as subtype 6e was
significantly higher in chronically-infected HCV mono-infection patients; one might speculate
that this is due to poor spontaneous clearance of acute HCV infection with genotype 6. The
prevalence of genotype 6 was significantly lower in HIV-HCV coinfection patients (specifically
subtype 6e). The reason for such difference is not known; however, possible explanations
include less exposure of HIV-infected patients to genotype 6 virus or poor transmission poten-
tial of genotype 6 in HIV-infected patients. It has been hypothesized that genotype 6e is indige-
nous to Vietnam and is subsequently spread to neighboring countries via drug trafficking
routes [50]. Subtype 6h, 6k, 6l, and 6p were also identified in a limited number of patients; this
supports the earlier hypothesis of the long endemic circulation of genotype 6 in Vietnam [23].
Genotype 2 viral strains were identified in 7.5% (24/322) patients. This includes 13 strains
of subtype 2a, 2 strains of 2b, and 9 strains of 2m. It has been hypothesized that subtype 2m
originates exclusively in Vietnam as it is not identified elsewhere [51]. HCV genotype 2 had
their ancestral origin in Africa and was brought outside Africa by European explorers. Since
Vietnam was a French colony in the 18th century; it is possible that the genotype 2 was intro-
duced to the country during the French colonization time [42].
Data on HCV subtype diversity is scanty in Vietnam as most diagnostic kits are not
designed to accurately determine the extensive and evolving HCV subtypes. Most clinical labo-
ratories use HCV kits using 5’ UTR region as target for genotyping. It has been reported earlier
that the 5’UTR based genotyping has poor discriminatory power to differentiate between
Genotype 1 and 6 [52]. Furthermore, the subtypes are evolving due to continuous generation
of quasispecies within an infected individual. 15% of the viral strains in our study had discor-
dant genotype when different RNA regions (5’UTR, Core or NS5B) were used for genotyping.
However, the majority of the isolates having discordant genotypes belong to genotype 6e. The
5’ UTR region of genotype 1 and 6 have high similarity, and our data further demonstrate that
in the majority of genotype 6e isolates, the 5’UTR sequence cannot discriminate between
Genotype 1a, 1b and 6e. Regions with high prevalence of genotype 6 viral strains should con-
sider NS5B sequence based genotyping methods.
The presence of recombinant/mixed strains in HCV patients has been reported earlier [53,
54]. Based on the genotype/subtype difference between core and NS5B sequences, 2.2% (7/
322) of the viral strains in our study had evidence of mixed/recombinant HCV infection. All
mixed/recombinant strains were between genotype 1 and 6; the major genotype in Vietnam.
Among these seven patients, 71.5% (5/7) were HIV-HCV co-infected and had history of IDU.
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The presence of recombinant/mixed strains in a single individual may be due to multiple
sequential infections with different genotype/subtype strains or due to super infection with a
different genotype/subtype or infection with a mixed genotype viral strains. However, further
investigation is necessary to characterize these recombinant strains. The diversity of the viral
strains from acutely-infected patients was higher than in chronically-infected patients. It is
possible that the high diversity of the viral strains in acute infection are facilitated by the active
replication phase that is not influenced by host immunogenetic factors. Next generation
sequencing and analysis of quasispecies during acute infection is necessary to understand the
extent of diversity as well as the factors that influence viral evolution within host.
We compared HCV RNA and liver enzyme (ALT, AST, albumin, bilirubin, GGT, AFP) lev-
els in acute, HCV mono-infection, and HIV-HCV coinfection. As expected, HCV RNA and
liver enzyme levels were higher in acutely-infected patients. HCV RNA and liver enzyme levels
in acute, HCV mono-infection, and HIV-HCV coinfection were similar among different geno-
types. We have limited number of genotypes in our study and further studies with more geno-
types are necessary to explore the hepatic pathogenic potential of different HCV genotypes.
A difference in distribution of HCV genotypes was noted in Central and Southern Vietnam.
While genotype 1 was common in both regions, genotype 6 was relatively common in South-
ern region. This is consistent with a recent report describing a predominance of genotype 6
(52.97%; 125/236) in blood donors and patients with liver diseases in Ho Chi Minh City [23].
The prevalence of genotype 3 was significantly high in central Vietnam especially in the Cen-
tral Highlands sub-region. In the South East and Mekong Delta sub regions, genotype 2 consti-
tutes 10% and 7% of the viral strains respectively. Further epidemiological studies are essential
to understand the underlying reasons for the difference in geographic distribution of HCV
genotypes in Vietnam. Knowledge of different risk behaviors of vulnerable populations and of
modes of transmission of the circulating viral strains in these sub regions will inform public
health prevention strategies.
Prior to the development of DAAs, IL-28B SNP typing was used to predict response to
interferon based therapy for HCV patients. Although there is a strong relationship between
SNP at or near the IL-28B gene and the SVR with pegINF/RBV treatment for chronic hepatitis
C [55], routine testing is not recommended in HCV management guidelines in Vietnam [56].
This is likely due to cost associated with IL28B SNP detection and lack of available technolo-
gies. We explored the association of IL28 genotype with acute infection and found no signifi-
cant difference between in IL28B SNP (rs12979860 and rs8099917) between the non-HCV-
infected control group and the acutely-infected patients. However, we identified significantly
higher prevalence of CC allele at rs12979860 between acute and chronic HCV infection
groups. This suggests that CC allele might be favorable for spontaneous clearance of infection
after acute HCV infection [18]. Besides this, a recent study in Thailand has shown that CC
allele is associated with higher SVR (84.2% vs. 59.5%, p<0.001) in chronically-infected patients
treated with PegINF/RBV [57].
Our data have limitations; namely, patients were recruited from provincial hospitals and
may not be representative of acute HCV infection in Vietnam. Generally, patients visit their
nearest medical facilities including private practitioners and district hospitals. Patients are gen-
erally referred to provincial hospitals only if they have severe disease or are living near provin-
cial hospitals. The spatial analysis in our study could be biased by hospital referral practice.
Additionally, the referral of patients to provincial hospitals is influenced by several factors
including the socioeconomic status of the patient. Data on chronic HCV infection may be
biased as patients who were cured after treatment were not available. The sample size for the
IL28B SNP analysis might not be robust enough to draw any conclusion. Our data on viral
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diversity might benefit from further analysis using next generation sequencing and analysis of
quasispecies to understand the genetic evolution within host and population.
In summary, we report a large study on HCV genotype and subtype, including for the first
time data on acute HCV infection in Vietnam. Our data suggests that the genotype 1a and 1b
is common in Vietnam. Genotype 6 is the second most common genotype and is more preva-
lent in chronic HCV mono-infection patients. Subtype 6e infection is often misdiagnosed as
1a or 1b using commercial genotyping assays; therefore, correct determination of genotype
using NS5B sequence is essential for evaluating the success of DAAs in geographic regions
where HCV genotype 6 is prevalent.
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